Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Bioanalytical Systems, Inc. | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: Bioanalytical Systems, Inc.

Preclinical services offsets decline in bioequivalence studies

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Bioanalytical Systems, Inc.

4Q Revenues: $5.2 million (+4%)

4Q Loss: $2.0 million (loss of $721,000 4Q15)

FY Revenues:$20.4 million (-10%)

FY Loss: $3.2 million (earnings were $1.1 million FY15)

Comments: Service revenue for the year was negatively impacted by fewer bioequivalence studies as well as fewer samples received and analyzed, as well as an increase in method development and validation projects, which generate lower revenue but involve more dedicated resources.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters